Rectal cancer. Optimizing by partial or total mesorectal excision;Rektumkarzinom. Optimierung durch partielle oder totale Mesorektumentfernung

Zentralblatt fur Chirurgie

Volumn 124, Issue 5, 1999, Pages 428-435

  Maurer, C A ^b   Renzulli, P ^b   Meyer, J D ^b   Buchler M W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

Continence; Lymphadenectomy; Mesorectum; Rectal neoplasms; Surgery

Indexed keywords

ARTICLE; CANCER SURGERY; HUMAN; PELVIS FLOOR; PELVIS LYMPHADENECTOMY; RECTUM CANCER; RECTUM RESECTION; SURGICAL TECHNIQUE;

EID: 0033038770     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Abulafi AM. Williams NS (1994) Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 81: 7-19
2. Adam IJ, Mohamdee MD, Martin IG, et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344: 707-710
3. Büchler MW, Heald RJ, Maurer CA, Ulrich B: Hrsg (1998) Rektumkarzinom: Das Konzept der totalen mesorektalen Exzision. Basel: Karger
4. Büchler MW, Maurer CA, Säuberli H; Hrsg (1995) Kontinenzerhaltung beim Rektumkarzinom. Chir Gastroenterol 11: 4
5. DeHaas-Kock DFM, Baeten CGMI, Jager JJ, Langendijk LJ, Volovics A, Arends JW (1996) Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 83: 781-785
6. Docherty JG, McGregor JR, Rurdie CA, Galloway DJ, O'Dwyer PJ (1995) Efficacy of tumouricidal agents in vitro and in vivo. Br J Surg 82: 1050-1052
7. Enker WE, Thaler HT, Cranor ML, Polyak T (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181: 335-346
8. Enker WE (1997) Total mesorectal excision - the new golden standard of surgery for rectal cancer. Ann Med 29:127-133
9. Expert Advisory Group (1996) Guidelines for the management of colorectal cancer. Royal College of Surgeons of England and Ireland
10. Fielding LP (1993) Mesorectal excision for rectal cancer. Lancet 341: 471-472
11. Fielding LP (1988) The portal vein and colorectal cancer. Br J Surg 75: 402-403
12. Goldberg PA, Nicholls RJ (1995) Prediction of local recurrence and survival of carcinoma of the rectum by surgical and histopathological assessment of local clearance. Br J Surg 82:1054-1056
13. Grinnell RS (1966) Lymphatic block with atypical and retrograde lymphatic metastasis and spread in carcinoma of the colon and rectum. Ann Surg 163: 272-280
14. Heald RJ, Maurer CA (1998) Langzeitresultate nach totaler mesorektaler Exzision. In: Büchler MW, Heald RJ, Ulrich B, Maurer CA (Hrsg) Rektumkarzinom: das Konzept der totalen mesorektalen Excision. Basel: Karger
15. Heald RJ, Maurer CA (1998) Totale mesorektale Exzision beim Rektumkarzinom: Prinzip und Technik. In: Büchler MW, Heald RJ, Ulrich B, Maurer CA (Hrsg) Rektumkarzinom: das Konzept der totalen mesorektalen Excision. Basel: Karger
16. Heald RJ, Husband EM, Ryall RDH (1982) The mesorectum in rectal cancer surgery - the clue to pelvic recurrence ? Br J Surg 69: 613-616
17. Heald RJ, Ryall RDH (1986) Recurrence and survival after total mesorectal excision for rectal cancer Lancet I: 1479-1482
18. Heald RJ (1988) The "holy plane" of rectal surgery. JR Soc Med 81: 503-508
19. Heald RJ (1995) Total mesorectal excision is optimal surgery for rectal cancer. A Scandinavian consensus. Br J Surg 82: 1297-1299
20. Heald RJ (1995) Reklumkarzinom: Die Rolle der totalen mesorektalen Exzision. Chir Gastroenterol 11: 334-339
21. Hermanek P, Gall FP (1981) Der aborale Sicherheitsabstand bei der sphinctererhaltenden Rektumresektion. Chirurg 52: 25-29
22. Hermanek P, Wiebelt H, Staimmer D, Riedl S, German Study Group Colo-Rectal Carcinoma (SGCRC) (1995) Prognostic factors of rectum carcinoma. Experience of the German Multicentre Study SGCRC. Tumori 81(Suppl): 60-64
23. Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K (1997) Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg 184: 584-588
24. Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMA, Todd IP (1986) The grading of rectal cancer: Historical perspectives and a multivariate analysis of 447 cases. Histopathology 10: 437-459
25. Joyce WP, Dolan J, Hyland J (1993) The mesorectum: re-appraisal of its morphology and ist unique importance in rectal cancer. Int J Colorectal Dis 8: 235
26. Kettlewell MGW (1994) Colorectal cancer and benign tumours of the colon. In: Morris PJ, Malt RA (Hrsg) Oxford textbook of surgery, S 1060-1088. Oxford Medical Publications, Oxford
27. Kwok SPY, Lau WY, Leung KL, Liew CT, Li AKC (1996) Prospective analysis of the distal margin of clearance in anterior resection for rectal carcinoma. Br J Surg 83: 969-972
28. Leather AJM, Yiu CY, Baker LA, Boulos PB, Northover JMA, Phillips RKS (1991) Passage of shed intraluminal colorectal cancer cells across a sealed anastomosis. Br J Surg 78: 756
29. Lippert H, Gastinger I (1995) Die chirurgische Qualitätssicherung am Beispiel der operativen Therapie des colorectalen Carcinoms. Chirurg 66: 344-349
30. MacFarlane JK, Ryall RDH, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341: 457-460
31. Madsen M, Christiansen J (1986) Distal intramural spread of rectal carcinomas. Dis Colon Rectum 29: 279-282
32. Maurer CA, Goekenjan M, Krähenbühl L, Büchler MW (1996) Therapie des Rektumkarzinoms: Onkologisch adäquate Therapie ist entscheidend. Ther Umschau 11: 829-838
33. Maurer CA, Renzulli P, Büchler MW (1998) Bedeutung des Sicherheitsabstandes für die Rektumkarzinomchirurgie. In: Büchler MW, Heald RJ, Ulrich B, Maurer CA (Hrsg) Rektumkarzinom: das Konzept der totalen mesorektalen Excision. Basel: Karger
34. Maurer CA. Z'graggen K, Büchler MW (1995) Wie weit soll Sphinktererhaltung gehen? Chir Gastroenterol 11: 351-356
35. McArdle CS, Hole D (1991) Impact of variability among surgeons on postoperative morbidity and mortality und ultimate survival. Br Med J 302: 1501-1505
36. McCall JL, Cox MR, Wattchow DA (1995) Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 10:126-132
37. McCall JL (1997) Total mesorectal excision: evaluating the evidence. Aust NZ J Surg 67:599-602
38. Metzger U (1987) Aetiologie und Pathogenese des Dickdarmkarzinoms. Bern Stuttgart Toronto: Huber
39. Moriya Y, Hojo K, Sawada T, Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32: 307-315
40. Moriya Y, Sugihara K, Akasu T, Fujita S (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21: 728-732
41. O'Dwyer PJ, Martin EW jr (1989) Viable intraluminal tumour cells and local/regional tumour growth in experimental cancer. Ann R Coll Surg Engl 71: 54-56
42. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. CA Cancer J Clin 47: 5-27
43. Penfold JCB (1974) A comparison of restorative resection of carcinoma of the middle third of the rectum with abdominoperineal excision. Aust NZ J Surg 44: 354-356
44. Pezim ME, Nicholls RJ (1984) Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer. Ann Surg 200 6: 729-733
45. Phillips RKS, Hittinger R, Blesovsky L, Fry JS, Fielding LP (1984) Local recurrence following "curative" surgery for large bowel cancer: I. The overall picture. Br J Surg 71: 12-16
46. Pollett WG, Nicholls RJ (1983) The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg 198: 159-163
47. Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1: 996-998
48. Raymond L. Bulliard JL, Levi F, Enderlin F, Mean A, Schüler G, Torhorst J (1994) Estimating the incidence of cancers in Switzerland: 1983-1987. Eur J Cancer 30: 978-982
49. Riedl St, Wiebelt H, Bergmann U, Hermanek P Jr (1995) Postoperative Komplikationen und Letalität in der chirurgischen Therapie des Coloncarcinoms. Ergebnisse der deutschen Multizenterstudie der Studiengruppe Kolorektales Karzinom (SGKRK). Chirurg 66: 597-606
50. Rutegard J, Sandzen B, Stenling R, Wiig J, Heald RJ (1997) For debate: Lateral rectal ligaments contain important nerves. Br J Surg 84: 1544-1545
51. Scott N, Jackson P, Al-Jaberi T, Dixon MF, Quirke P, Finan PJ (1995) Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 82: 1031-1033
52. Shirouzu K, Isomoto H, Kakegawa T (1995) Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer 76: 388-392
53. Steele RJC (1998) Colonic cancer. In: Phillips RKS (Hrsg) Colorectal surgery, S 43-75. London Philadelphia Toronto: Saunders
54. Stelzner F (1962) Die gegenwärtige Beurteilung der Rektumresektion und Rektumamputation beim Mastdarmkrebs. Bruns Beitr 204: 41-47
55. Sugihara K, Moriya Y, Akasu T, Fujita S (1996) Pelvic autonomic nerve preservation for patients with rectal carcinoma. Cancer 78: 1871-1880
56. Surtees P, Ritchie JK, Phillips RKS (1990) High versus low ligation of the inferior mesenteric artery in rectal cancer. Br J Surg 77: 618-621
57. Taffinder NJ, Champault G (1996) Cells in surgical smoke. Br J Surg 83: 133
58. Umpelby HC, Williamson RCN (1984) The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl 66:1 92-194
59. Umpleby HC, Fermor B, Symes MO, Williamson RCN (1984) Viability of exfoliated colorectal carcinoma cells. Br J Surg 71:659-663
60. Vernava AM, Moran M (1992) A prospective evaluation of distal margins in carcinoma of the rectum. Surg Gynecol Obstet 175: 333-336
61. Weese JL, O'Grady MG, Ottery FD (1986) How long is the five centimeter margin? Surg Gynecol Obstet 163: 101-103
62. Wiggers T, Jeekel J, Arends JW (1988) No touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg 75: 409-415